Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     

  • GBP/USD

    1.2498
    -0.0013 (-0.10%)
     

  • Bitcoin GBP

    51,193.80
    -502.04 (-0.97%)
     

  • CMC Crypto 200

    1,333.28
    -63.26 (-4.53%)
     

  • S&P 500

    5,102.49
    +54.07 (+1.07%)
     

  • DOW

    38,269.23
    +183.43 (+0.48%)
     

  • CRUDE OIL

    83.87
    +0.30 (+0.36%)
     

  • GOLD FUTURES

    2,351.80
    +9.30 (+0.40%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

QLT Inc. (QLTI) in Focus: Stock Adds 6.9% in Session

Zacks Equity Research
Updated

QLT Inc. QLTI was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.36 to $1.44 in the past one-month time frame.

This Med-Drugs industry stock witnessed one negative estimate revision over the past 30 days. The Zacks Consensus Estimate also moved down over the same time frame, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

QLT has a Zacks Rank #3 (Hold).

QLT INC Price

 

QLT INC Price | QLT INC Quote

ADVERTISEMENT

However, a better-ranked stock in the same space is Acerus Pharmaceuticals Corporation TRLPF, sporting a Zacks Rank #1 (Strong Buy).

Is QLTI going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ACERUS PHARMS (TRLPF): Free Stock Analysis Report
 
QLT INC (QLTI): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research